Drug ID: | NPD586 |
Drug Name: | LMV-601 |
Molecular Formula: | C11H16OS2 |
Canonical SMILES: | [S-]C(=S)O[C@H]1C[C@H]2C[C@@H]1[C@H]1[C@@H]2CCC1 |
Standard InCHI: | InChI=1S/C11H16OS2/c13-11(14)12-10-5-6-4-9(10)8-3-1-2-7(6)8/h6-10H,1-5H2,(H,13,14)/p-1/t6-,7-,8-,9-,10+/m1/s1 |
Standard InCHIKey: | PWLXJBSAUKKGCM-IGORNWKESA-M |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB015187 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 227.06 |
ALogP | 0.5928 |
MLogP | 2.34 |
XLogP | 3.046 |
HDA | 1 |
HBD | 0 |
Rotatable Bonds | 3 |
TPSA | 41.32 |
RO5 Violation | 0 |